A going-private filing under Rule 13e-3, which requires extra disclosure precisely because the buyer is an insider or an affiliate.
| Company | Latest form | Filed | Filings |
|---|---|---|---|
| LGMK (LogicMark, Inc.) | SC 13E3 | 14 August 2026 | 3 |
| RAASY (Cloopen Group Holding Ltd) | SC 13E3/A | 11 August 2026 | 1 |
| PERF (Perfect Corp.) | SC 13E3 | 31 July 2026 | 1 |
| KORE Group Holdings, Inc. | SC 13E3/A | 21 July 2026 | 1 |
| IHS (IHS Holding Ltd) | SC 13E3/A | 10 July 2026 | 1 |
| CSCIF (COSCIENS Biopharma Inc.) | SC 13E3/A | 6 July 2026 | 1 |
| SELECT MEDICAL HOLDINGS CORP | SC 13E3/A | 1 July 2026 | 1 |
| Aptose Biosciences Inc. | SC 13E3/A | 1 July 2026 | 1 |
From the SEC's quarterly filing index for 2026 QTR3, read 19 August 2026.
Every page is built from the SEC's quarterly filing index, read 19 August 2026. Nothing here is investment advice, and a filing is not an outcome — deals are abandoned, outbid and blocked.